Qube Research & Technologies (QRT)
AIMT

Qube Research & Technologies (QRT)’s Aimmune Therapeutics AIMT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-51,590
Closed -$1.78M – 2362
2020
Q3 		$1.78M Buy
+51,590
New +$1.1M 0.03% 664

Qube Research & Technologies (QRT)'s AIMT Position: Q4 2020 in Review

Qube Research & Technologies (QRT) sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 51,590 shares — an estimated $1.78M sold.

Qube Research & Technologies (QRT) first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $1.78M in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • Qube Research & Technologies (QRT) reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 51,590 Aimmune Therapeutics shares in Q4 2020, an estimated $1.78M.
  • Qube Research & Technologies (QRT) first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Aimmune Therapeutics position peaked at $1.78M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2020, filed 16 Feb 2021.